(Q51729146)

10 April 2018

editorial

0 references

title

RNA interference, RSV, and lung transplantation: a promising future for siRNA therapeutics. (English)

1 reference

10 April 2018

1 reference

1 reference

Todd L Astor

1

1 reference

10 April 2018

language of work or name

English

0 references

publication date

1 February 2011

1 reference

10 April 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

10 April 2018

volume

183

1 reference

10 April 2018

issue

4

1 reference

10 April 2018

page(s)

427-428

1 reference

10 April 2018

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Single-stranded antisense siRNAs guide target RNA cleavage in RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

RNAi-based therapeutics-current status, challenges and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Expression profiling reveals off-target gene regulation by RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

RNAi therapeutics: a potential new class of pharmaceutical drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Strategies for in vivo delivery of siRNAs: recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1488ED

10.1164/RCCM.201009-1488ED

21 January 2018

Identifiers

DOI

1 reference

10 April 2018

release_uypclhgnejer3mk757lrp4skhi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uypclhgnejer3mk757lrp4skhi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

10 April 2018